The global aortic valve replacement market size was valued at USD 18.10 billion in 2025 and is projected to grow from USD 20.64 billion in 2026 to USD 58.89 billion by 2034, registering a CAGR of 14% during the forecast period from 2026 to 2034. Europe dominated the aortic valve replacement market with a market share of 38.6% in 2025.
Aortic valve replacement is a medical procedure used to replace a damaged or diseased aortic valve that cannot function properly. The procedure may involve replacing the valve with a mechanical valve, a biological tissue valve, or another suitable replacement device. It is commonly performed to treat conditions such as severe aortic stenosis or aortic valve regurgitation. Aortic valve replacement helps restore normal blood flow from the heart, reduce symptoms, improve heart function, and support better quality of life for eligible patients.
Download a Free Sample To learn more about this report,
TAVR Makes Valve Replacement Less Invasive
The aortic valve replacement market is shifting toward less invasive treatment as more patients become eligible for transcatheter aortic valve replacement (TAVR). Instead of opening the chest, TAVR allows doctors to place a replacement valve through a catheter. This can make treatment easier for selected patients and may reduce the recovery burden associated with open-heart surgery. Growing clinical evidence and improvements in valve technology are supporting aortic valve replacement market growth.
Earlier Intervention Creates New Treatment Opportunities
Aortic valve replacement is also moving toward earlier intervention for carefully selected patients rather than waiting until symptoms become severe. This change is encouraging doctors to assess patients more closely and consider factors such as disease progression, age, surgical risk, and overall health when deciding on treatment. As treatment options broaden, the aortic valve replacement market size is benefiting from greater use of both transcatheter and surgical valve replacement.
Growing Burden of Aortic Stenosis and Increasing Adoption of Minimally Invasive Procedures
The market is being supported by the growing need to treat severe aortic valve disease, particularly aortic stenosis among older adults. Alongside conventional surgical aortic valve replacement, transcatheter aortic valve replacement is becoming an important treatment option for appropriate patients because it can replace the diseased valve without conventional open-heart surgery. Advances in valve design and delivery systems are helping expand treatment options and supporting aortic valve replacement market demand.
High Procedure Costs and Complex Patient Selection
The market faces pressure from the high cost of valve replacement procedures, specialized cardiac facilities, imaging requirements, and post-procedure monitoring. Treatment selection is also complex because physicians must consider age, surgical risk, anatomy, life expectancy, valve durability, and other medical conditions when deciding between surgical and transcatheter replacement.
Expansion of Valve-in-Valve Procedures and Next-Generation TAVR Technologies
The market has significant opportunities as newer transcatheter valves and valve-in-valve procedures expand treatment possibilities for patients who have previously received bioprosthetic or transcatheter valves. Improvements in valve positioning, hemodynamics, delivery systems, and patient-specific treatment planning are shaping important aortic valve replacement market trends.
Balancing Minimally Invasive Treatment With Long-Term Valve Durability
The market continues to face the challenge of providing less-invasive procedures while ensuring that replacement valves remain safe and effective over the long term. This is particularly important as TAVR is increasingly considered for younger and lower-risk patients, who may live long enough to require another valve intervention. Physicians therefore need to balance faster recovery and lower procedural invasiveness against valve durability and future treatment options.
Minimal Invasive Surgery Segment Led the Market with a 64.7% Share in 2025
Minimal invasive surgery accounted for the largest share of the aortic valve replacement market in 2025, representing 64.7% and an estimated value of $11.72 billion. Minimally invasive approaches are gaining preference because they can reduce surgical trauma, shorten recovery periods, and offer less invasive treatment options for eligible patients. Growing adoption of advanced valve replacement techniques and improvements in surgical technology are supporting the segment's strong position.
Open surgery accounted for the remaining 35.3% of the market, valued at approximately $6.39 billion. It remains an important treatment option for patients who may not be suitable candidates for minimally invasive procedures or who require more extensive surgical intervention. Although its growth rate is lower at 6.8%, continued demand for established surgical approaches keeps open surgery an important part of the overall market.
Request Customizationto receive a tailored report.
Ambulatory Surgical Centres are Projected to Register the Fastest Growth at a CAGR of 9.6%
Ambulatory surgical centres are projected to be the fastest-growing end-user segment, with a CAGR of 9.6% during 2026–2034. The segment is benefiting from the increasing shift toward outpatient and shorter-stay procedures, supported by improvements in minimally invasive techniques and post-operative care. As suitable patients increasingly seek procedures that can reduce hospital stays and recovery time, ambulatory facilities are expected to gain a larger role in valve replacement care.
Hospitals accounted for the dominant 84.5% share in 2025, representing approximately $15.3 billion. Hospitals continue to handle the majority of aortic valve replacement procedures because they provide specialized cardiac teams, advanced diagnostic capabilities, intensive care facilities, and comprehensive post-operative support. Ambulatory surgical centres represented 15.5% of the market, valued at around $2.81 billion, and their faster projected growth indicates increasing opportunities for outpatient-based cardiac procedures.
Speak to an Analystto discuss market opportunities.
Europe accounted for the largest share of the global aortic valve replacement market, representing 38.6% of total revenue and reaching USD 6.99 billion in 2025. The region continues to lead due to its aging population, well-established cardiovascular healthcare infrastructure, and growing demand for advanced valve replacement procedures. Increasing adoption of minimally invasive techniques, improvements in transcatheter aortic valve replacement, and better access to specialized cardiac care are supporting market growth.
Germany represents a major European market, supported by its advanced cardiac care infrastructure and strong adoption of innovative heart valve procedures. Increasing prevalence of aortic stenosis among older adults and growing use of minimally invasive replacement techniques continue to create market opportunities.
The UK market is supported by expanding access to specialized cardiac services, increasing demand for advanced valve replacement procedures, and improvements in cardiovascular diagnosis. Growing adoption of transcatheter procedures is also contributing to market development.
Unlock Regional Insightsto access country-level data, & regional trends.
North America accounted for 31.4% of the global aortic valve replacement market, valued at USD 5.69 billion in 2025, and is projected to register the fastest CAGR of 9.1% during the forecast period. The regional market is driven by increasing prevalence of cardiovascular diseases, a growing elderly population, and rapid adoption of minimally invasive cardiac procedures. Continued technological advancements in valve replacement devices and expanding access to specialized cardiac centers are further accelerating market growth.
The US market represents the largest contributor in North America, supported by advanced cardiac healthcare infrastructure, high adoption of transcatheter procedures, and strong investments in cardiovascular medical technologies. Increasing diagnosis of aortic valve disorders and growing demand for less-invasive treatment options continue to strengthen market growth.
Canada's market is supported by an aging population, improving access to cardiovascular care, and increasing adoption of advanced valve replacement technologies. Growing investments in specialized cardiac services are also contributing to market expansion.
Asia Pacific accounted for 20.8% of the global aortic valve replacement market, reaching USD 3.77 billion in 2025, and is projected to grow at a CAGR of 8.7% during the forecast period. Rising healthcare expenditure, improving cardiac care infrastructure, and increasing awareness of advanced treatment options are driving regional market growth. The growing elderly population and expanding availability of minimally invasive procedures are further supporting demand.
China's market is benefiting from a rapidly aging population, expanding hospital infrastructure, and increasing access to advanced cardiovascular treatments. Growing investments in domestic medical device capabilities and rising adoption of minimally invasive valve procedures are creating additional opportunities.
Japan's market is supported by its aging population, advanced healthcare system, and strong demand for treatments for age-related cardiovascular conditions. Increasing adoption of transcatheter procedures and continued medical technology development are supporting market growth.
Middle East & Africa accounted for 4.0% of the global aortic valve replacement market, totaling USD 0.72 billion in 2025. Increasing healthcare investments, improving cardiovascular care infrastructure, and growing awareness of advanced cardiac procedures are supporting market development across the region. Expansion of specialized hospitals and greater access to modern valve replacement technologies are expected to create additional opportunities during the forecast period.
The UAE market is supported by investments in advanced cardiac hospitals, growing demand for specialized cardiovascular care, and increasing adoption of minimally invasive procedures. Development of medical tourism and advanced healthcare infrastructure is also creating additional opportunities.
Africa's market is benefiting from gradual improvements in cardiovascular healthcare infrastructure, increasing awareness of heart valve disorders, and expanding access to specialized medical services. As investments in cardiac centers and advanced treatment technologies increase, opportunities for aortic valve replacement procedures are expected to expand.
Customize This Report to Match Your Strategic Objectives
Author's Details
Healthcare Lead
Debashree Bora is a strategic healthcare research professional with nearly eight years of hands on experience in market intelligence, encompassing primary research, secondary research, market estimation, and consulting engagements. She specializes in pharmaceutical, biotechnology, medical devices, healthcare services, clinical trials, and healthcare outsourcing sectors, providing actionable insights on evolving industry trends, regulatory landscapes, competitive dynamics, and market opportunities. Debashree’s research helps global clients evaluate market potential, identify growth opportunities, strengthen commercial strategies, and make informed business decisions.
Her work focuses on assessing treatment landscapes, outsourcing models, technology adoption, market access dynamics, regulatory developments, and competitive positioning across healthcare and life sciences industries. Debashree has consistently supported organizations in understanding market gaps, evaluating revenue potential, developing market entry strategies, and shaping expansion plans across complex and fast evolving healthcare markets.
With a strong analytical foundation and structured research approach, she excels at synthesizing large datasets, stakeholder inputs, and market signals into actionable insights that guide strategic decision making. Her healthcare expertise enables her to connect clinical, commercial, and operational developments with business opportunities, helping stakeholders anticipate shifts and capitalize on emerging growth areas. Debashree’s consulting oriented mindset and deep healthcare industry understanding make her a trusted advisor to businesses navigating dynamic and rapidly evolving healthcare markets.
Hemostasis & Tissue Sealing Agents Market Size, Share, 2034
Extremity Tissue Expanders Market Size, Share, Growth, Analysis, 2034
Vaginal Rejuvenation Market Size, Share, Growth, Analysis, 2034
Brachytherapy Market Size, Share, Growth, Analysis, Report, 2034
Assisted Walking Devices Market Size, Share, Growth, 2034
Spirometer Market Size, Share, Growth, Analysis, Report, 2034
We are featured on:
sales@straitsresearch.com